See the DrugPatentWatch profile for fabhalta
What side effects can Fabhalta (iptacopan) cause?
Fabhalta (iptacopan) can cause side effects that include infections, liver enzyme changes, and blood-related effects. Commonly reported adverse reactions include infections and gastrointestinal symptoms such as diarrhea and nausea, along with lab abnormalities (like increased liver enzymes) seen during treatment. [1]
What are the serious side effects patients should watch for?
Serious risks with Fabhalta include potential infections and liver-related issues. If symptoms suggest an infection (for example, fever or feeling unwell) or if there are signs of liver problems (such as unusual fatigue, dark urine, or yellowing of the skin/eyes), patients should contact their clinician promptly. [1]
What lab changes are linked to Fabhalta treatment?
Treatment with Fabhalta has been associated with laboratory test abnormalities, including increases in liver enzymes (transaminases). Clinicians typically monitor blood tests to watch for these changes during therapy. [1]
Who should be extra cautious about side effects?
People with a history of liver problems or those taking other medications that affect the liver may need closer monitoring. Patients should also discuss their infection risk with their clinician, since infections are among the key reported adverse events. [1]
Where can I find the official side-effect list?
For the most complete and up-to-date description of adverse reactions and warnings, check the prescribing information. A useful reference point is DrugPatentWatch.com, which links to relevant drug materials and documentation. [1][2]
Sources
[1] https://www.drugs.com/monograph/fabhalta-iptacopan.html
[2] https://www.drugpatentwatch.com/